CRVS

Conviction 47HealthcareScan · Thu, Jun 25, 2026

Three white soldiers

CRVS$13.06+0.81%

ResistanceSupportVol 14Insider buy

Vol MA14 1.39M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Corvus Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.corvuspharma.com ↗

Price13.06

Change+0.81%

Gap-0.77%

Rel volume2.61×

Avg volume1.52M

Avg $ vol18.33M

SMA 2011.94

SMA 5013.67

SMA 20011.98

Price vs 50-4.46%

Price vs 200+8.96%

MA stackmixed

50/200 cross—

Supertrenddown · 13.55

RSI (14)56

MACD hist0.29

MACD crossbull · 8d

Stoch %K / %D83 / 85

ADX (14)14

+DI / −DI21 / 15

RSI divergenceBullish

MACD divergenceBullish

ATR %+6.20%

ADR %5.59%

52w high25.52

52w low3.86

From 52w high-48.84%

Above 52w low+238.21%

New 52w highNo

SqueezeOff

Bollinger width19.19%

%B0.98

Donchian pos82.71%

Donchian high13.52

Donchian low10.83

AVWAP (52w high)16.14

vs AVWAP high-19.11%

AVWAP (52w low)14.20

vs AVWAP low-8.07%

OBV trendFlat

Chaikin MF (20)-0.19

Today vs 20d2.61×

Avg vol (14d)1.39M

Avg vol (20d)1.52M

Avg $ vol (20d)18.33M

Market cap1.1B

RS 3m (vs SPY)-13.78%

RS 6m (vs SPY)+65.16%

RS line new highNo

Trend template4/8

Technical rank71.3

1 week+8.79%

1 month+1.75%

3 months-8.19%

6 months+67.37%

1 year+200.81%

YTD+78.35%

P/E-71.83

P/B4.56

P/S—

P/FCF-33.30

EPS-0.5300

Div yield—

ROE-6.35%

ROA-6.04%

Debt/Eq—

Current19.81

EV/EBITDA-24.67

Gross margin—

Net margin—

Rev growth—

EPS growth75.47%

Price target31.60

Target upside142.05%

Analyst ratingBuy

Institutional87.86%

Ent. value1.06B

Revenue—

Net income-13.69M

Gross profit—

Free cash flow-32.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out84.09M

Employees37

ListedWed, Mar 23, 2016

Free float58.06M

Float %69.3%

Short interest17.32M

Days to cover8.4d

Short volume49.4%

Squeeze score86 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.17 · 2 est

Last EPS vs est−$0.15 vs −$0.14

Last surprise-7.1% miss

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank71.3 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRVS

All disclosures →

No recent disclosed trades by Congress in CRVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRVS · 3 buys

Insider	Side	Shares	Value	Traded	Filed
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	5K	$60K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	1.93K	$23K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Other	—	—	2026-05-18	2026-05-20
Chan Andrew C. Director · Stock Option (Right to Buy) · 2026-04-23	Grant	30K	$0	2026-04-23	2026-04-27

SEC filings

EDGAR filings in CRVS · 1 recent

EDGAR →

8-K8-KFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.